Jorge Diaz, DO
Internal Medicine · Hialeah, FLNPI 1346279809
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,020 of the $5,627 with a category attached, or 71.4%. Abbott accounts for 84.2% of it on its own, with 8 other manufacturers making up the rest. Among internal medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 124 payments — averaging $45.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$5K
- Novo Nordisk AS$400
- AbbVie$381
- Boehringer Ingelheim$26
- Radius Health, Inc.$23
- Novo Nordisk$20
- plus $40 from 3 others
Across 610 payments — averaging $33,926 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$8.8M
- Bavarian Nordic A/s$6.7M
- Pfizer$4M
- Adamis Pharmaceuticals Corporation$281K
- Sanofi US Services Inc.$239K
- Almirall LLC$180K
- plus $521K from 9 others
What the payments were for
- Travel & lodging$1,60729%
- Food & beverage$4,02071%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 93 | $4,737 |
| Novo Nordisk AS | 1 | $400 |
| AbbVie(2 entities) | 24 | $381 |
| Boehringer Ingelheim | 1 | $26 |
| Radius Health, Inc. | 1 | $23 |
| Novo Nordisk | 1 | $20 |
| Lilly USA, LLC | 1 | $15 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $13 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$2,526
- AMPLATZER AMULET$443
- ENSITE PRECISION$153
- ENSITE$141
- EnSite Precision Cardiac Mapping System$127
How this compares
$5,627 in reported general payments places this provider in the 90th percentile of 8,530 internal medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 241 | $302,172 |
| JanuviaSitagliptin Phosphate | 40 | $47,354 |
| EliquisApixaban | 13 | $20,533 |
| EntrestoSacubitril/Valsartan | 19 | $20,185 |
| OzempicSemaglutide | 17 | $16,111 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 16 | $14,259 |
| JardianceEmpagliflozin | 13 | $13,167 |
| MyrbetriqMirabegron | 18 | $12,273 |
| SynthroidLevothyroxine Sodium | 22 | $3,069 |
| Omeprazole | 79 | $1,647 |
| Vitamin D2Ergocalciferol (Vitamin D2) | 119 | $1,620 |
| Ibuprofen | 85 | $1,561 |
| Gabapentin | 73 | $1,524 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 39 | $1,466 |
| Ventolin HfaAlbuterol Sulfate | 16 | $1,357 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Humulin 70-30 | $15 | $302,764254 claims |
| Novo NordiskOzempic | $20 | $16,11117 claims |
| Boehringer IngelheimJardiance | $26 | $13,16713 claims |
| AbbVieSynthroid | $381 | $3,06922 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Hialeah
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
- Bianka EperjesiovaGainesville$260K
- Julio ConradoFort Myers$247K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.